Literature DB >> 34729627

Imaging translocator protein expression with positron emission tomography.

Catriona Wimberley1,2, Irene Buvat3, Hervé Boutin4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34729627     DOI： 10.1007/s00259-021-05601-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  22 in total

Review 1.  Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.

Authors:  Bieneke Janssen; Robert H Mach
Journal:  Prog Mol Biol Transl Sci       Date:  2019-05-02       Impact factor: 3.622

Review 2.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

3.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

Authors:  Federico E Turkheimer; Paul Edison; Nicola Pavese; Federico Roncaroli; Alexander N Anderson; Alexander Hammers; Alexander Gerhard; Rainer Hinz; Yan F Tai; David J Brooks
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

4.  An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.

Authors:  David R Owen; Astrid J Yeo; Roger N Gunn; Kijoung Song; Graham Wadsworth; Andrew Lewis; Chris Rhodes; David J Pulford; Idriss Bennacef; Christine A Parker; Pamela L StJean; Lon R Cardon; Vincent E Mooser; Paul M Matthews; Eugenii A Rabiner; Justin P Rubio
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-19       Impact factor: 6.200

5.  Imaging translocator protein expression with positron emission tomography.

Authors:  Catriona Wimberley; Irene Buvat; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12       Impact factor: 9.236

6.  Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.

Authors:  David R Owen; Nehal Narayan; Lisa Wells; Luke Healy; Erica Smyth; Eugenii A Rabiner; Dylan Galloway; John B Williams; Joshua Lehr; Harpreet Mandhair; Laura An Peferoen; Peter C Taylor; Sandra Amor; Jack P Antel; Paul M Matthews; Craig S Moore
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-22       Impact factor: 6.200

Review 7.  Supervised clustering for TSPO PET imaging.

Authors:  Julia Schubert; Matteo Tonietto; Federico Turkheimer; Paolo Zanotti-Fregonara; Mattia Veronese
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-29       Impact factor: 9.236

Review 8.  Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies.

Authors:  Fabien Chauveau; Guillaume Becker; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-13       Impact factor: 9.236

Review 9.  Cellular sources of TSPO expression in healthy and diseased brain.

Authors:  Erik Nutma; Kelly Ceyzériat; Sandra Amor; Stergios Tsartsalis; Philippe Millet; David R Owen; Vassilios Papadopoulos; Benjamin B Tournier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-12       Impact factor: 9.236

10.  Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain.

Authors:  Erik Nutma; Emeline Gebro; Manuel C Marzin; Paul van der Valk; Paul M Matthews; David R Owen; Sandra Amor
Journal:  Glia       Date:  2021-06-19       Impact factor: 7.452
View more
  2 in total

1.  Imaging translocator protein expression with positron emission tomography.

Authors:  Catriona Wimberley; Irene Buvat; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12       Impact factor: 9.236

Review 2.  What value can TSPO PET bring for epilepsy treatment?

Authors:  Viviane Bouilleret; Stefanie Dedeurwaerdere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.